-
Jain, A. P., Aggarwal, K. K., & Zhang, P. Y. (2015). Omega-3 fatty acids and cardiovascular disease. Eur Rev Med Pharmacol Sci, 19(3), 441-5: https://pubmed.ncbi.nlm.nih.gov/25720716/
-
Elagizi, A., Lavie, C. J., O’keefe, E., Marshall, K., O’keefe, J. H., & Milani, R. V. (2021). An update on omega-3 polyunsaturated fatty acids and cardiovascular health. Nutrients, 13(1), 204: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827286/
-
Bornfeldt, K. E. (2021). Triglyceride lowering by omega-3 fatty acids: A mechanism mediated by N-acyl taurines. The Journal of Clinical Investigation, 131(6): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954591/
-
Eslick, G. D., Howe, P. R., Smith, C., Priest, R., & Bensoussan, A. (2009). Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. International journal of cardiology, 136(1), 4-16: https://pubmed.ncbi.nlm.nih.gov/18774613/
-
Bernstein, A. M., Ding, E. L., Willett, W. C., & Rimm, E. B. (2012). A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. The Journal of nutrition, 142(1), 99-104: https://pubmed.ncbi.nlm.nih.gov/22113870/
-
Naini, A. E., Keyvandarian, N., Mortazavi, M., Taheri, S., & Hosseini, S. M. (2015). Effect of Omega-3 fatty acids on blood pressure and serum lipids in continuous ambulatory peritoneal dialysis patients. Journal of research in pharmacy practice, 4(3), 135: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548432/
-
Zhang, X., Ritonja, J. A., Zhou, N., Chen, B. E., & Li, X. (2022). Omega‐3 polyunsaturated fatty acids intake and blood pressure: a dose‐response meta‐analysis of randomized controlled trials. Journal of the American Heart Association, 11(11), e025071: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238708/
-
Kavyani, Z., Musazadeh, V., Fathi, S., Faghfouri, A. H., Dehghan, P., & Sarmadi, B. (2022). Efficacy of the omega-3 fatty acids supplementation on inflammatory biomarkers: An umbrella meta-analysis. International Immunopharmacology, 111, 109104: https://pubmed.ncbi.nlm.nih.gov/35914448/
-
Calder, P. C. (2013). Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. British journal of clinical pharmacology, 75(3), 645-662: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575932/
-
Zirpoli, H., Chang, C. L., Carpentier, Y. A., Michael-Titus, A. T., Ten, V. S., & Deckelbaum, R. J. (2020). Novel approaches for omega-3 fatty acid therapeutics: chronic versus acute administration to protect heart, brain, and spinal cord. Annual review of nutrition, 40, 161-187: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717546/
-
Endo, J., & Arita, M. (2016). Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. Journal of cardiology, 67(1), 22-27: https://www.sciencedirect.com/science/article/pii/S0914508715002300
-
Zanetti, M., Grillo, A., Losurdo, P., Panizon, E., Mearelli, F., Cattin, L., ... & Carretta, R. (2015). Omega-3 polyunsaturated fatty acids: structural and functional effects on the vascular wall. BioMed research international, 2015: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537737/
-
Khatana, C., Saini, N. K., Chakrabarti, S., Saini, V., Sharma, A., Saini, R. V., & Saini, A. K. (2020). Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxidative medicine and cellular longevity, 2020: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512065/
-
Dighriri, I. M., Alsubaie, A. M., Hakami, F. M., Hamithi, D. M., Alshekh, M. M., Khobrani, F. A., ... & Tawhari, M. (2022). Effects of omega-3 polyunsaturated fatty acids on brain functions: a systematic review. Cureus, 14(10): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641984/
-
Mohebi-Nejad, A., & Bikdeli, B. (2014). Omega-3 supplements and cardiovascular diseases. Tanaffos, 13(1), 6: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153275/